Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

One medical device used to assist manage diabetes, both type 1 and type 2, is the continuous ... 218 percentage points (see more details here). DexCom, Inc. (NASDAQ:DXCM), founded in 1999 and ...

Dexcom State of Type 2 Report: Access and Attitudes Across ... new Dexcom G7 15 Day sensor1 will be presented on March 20 at 1 p.m. CET in Hall D. With a MARD of 8.0%,2 Dexcom G7 15 Day will ...

Treatments for Type 2 diabetes and new clinical trial data ... Here are three highlights from the first day of the conference: 1. Dexcom previews new data for 15-day glucose monitor Dexcom shared ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system,1 ...